Introduction to Testing for Drugs of Abuse

Regular price €69.99
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
A01=William E. Schreiber
Author_William E. Schreiber
Category=PN
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science

Product details

  • ISBN 9781119794059
  • Weight: 340g
  • Dimensions: 152 x 229mm
  • Publication Date: 05 May 2022
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: US
  • Product Form: Paperback
Secure checkout Fast Shipping Easy returns

An Introduction to Testing for Drugs of Abuse

An Introduction to Testing for Drugs of Abuse presents a distilled set of facts about the major drugs of abuse that are encountered in clinical practice. Individual chapters highlight the similarities in chemical structure, mechanism of action, and physiologic effects of each drug group, as well as their metabolism, therapeutic uses and potential for misuse or abuse. Special attention is given to the testing process, with an emphasis on interpretation of test results.

Informative and entertaining cases appear at the end of each chapter. These cases illustrate the many situations in which drug testing is performed for medical, legal and employment purposes.

Written in clear, concise language, this book provides practical guidance to pathologists, clinical chemists and technologists who are responsible for reporting and interpreting the results of drug analyses. It will be especially useful to residents and students who are learning about toxicology for the first time. Clinical practitioners – doctors, nurses, pharmacists and other health care professionals – will find the information they need to order and interpret drug tests accurately.

For more information watch the trailer here:  https://players.brightcove.net/4931690914001/B1xdbomRDl_default/index.html?videoId=6310075842112

About the Author

William E. Schreiber is a Professor in the Department of Pathology and ­Laboratory Medicine at The University of British Columbia and Clinical Director of Chemistry at LifeLabs. Previously, he was a consultant pathologist at Vancouver General Hospital and medical director of the British Columbia Provincial Toxicology Centre. He is a past president of the American Society for Clinical Pathology.

More from this author